"Our technology has the potential to enhance the therapeutic effectiveness of cell-based therapies and make them more affordable.”
"Our technology has the potential to enhance the therapeutic effectiveness of cell-based therapies and make them more affordable.”
"Our technology has the potential to enhance the therapeutic effectiveness of cell-based therapies and make them more affordable.”
CrowdScan provides accurate and privacy-friendly crowd measurement data.
"As the first-ever digital health app to be reimbursed in Belgium, we are setting the standard for healthcare’s transition to value-based (digital) care."
"As the first-ever digital health app to be reimbursed in Belgium, we are setting the standard for healthcare’s transition to value-based (digital) care."
"As the first-ever digital health app to be reimbursed in Belgium, we are setting the standard for healthcare’s transition to value-based (digital) care."
Accelleran provides OpenRAN Software solutions for operators of 5G networks.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
"The aim is to have one of the most prominent photonics hubs in Europe, and even globally, located in Ghent."
"The aim is to have one of the most prominent photonics hubs in Europe, and even globally, located in Ghent."
"The aim is to have one of the most prominent photonics hubs in Europe, and even globally, located in Ghent."
Blue Foot provides water-intensive industries with the technology to reuse water.
"MicroLED displays could take out all the currently available display types. It would be great if QustomDot could facilitate this.”
"MicroLED displays could take out all the currently available display types. It would be great if QustomDot could facilitate this.”
"MicroLED displays could take out all the currently available display types. It would be great if QustomDot could facilitate this.”
MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.
Qbic fund is a seed and early-stage venture capital fund, supporting spin-offs or start-ups that valorize research from Qbic's knowledge partners.
A knowledge partner spin-off, i.e. a company that was founded based on technological innovations originating at Qbic's partner universities, research institutes or hospitals.
A start-up linked to a knowledge partner, i.e. a company with a strong R&D collaboration with one of Qbic's knowledge partners. This collaboration can be structured through joint development contracts, clinical studies, IP license agreements, etc.
.jpg)
%20600%20400.jpg)
